Teixobactin development for anthrax
Ended Project Grant Awarded Last action
- Award ID
- R44AI152657
- Recipient
-
Novobiotic Pharmaceuticals, LLC UEI GUV4CZLZE5Z2
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,974,724
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $4,978,322.00 Federal
- $996,402.00 Non-federal
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $992,770 | $0 | |
| Amendment | $992,770 | $0 | |
| Amendment | $996,402 | $0 | |
| Amendment | $996,402 | $996,402 | |
| Original award | $999,978 | $0 |
Quick answers
Who received award R44AI152657?
R44AI152657 was awarded to Novobiotic Pharmaceuticals, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 15, 2020.
How much is award R44AI152657 worth?
$5,974,724 has been obligated on R44AI152657: $4,978,322 in federal funding and $996,402 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award